@article{0450f3a4e8b148e5bf866c77ecd2bfc4,
title = "Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study",
abstract = "The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP ",
keywords = "Aged, Aged, 80 and over, Antihypertensive Agents, Atenolol, Electrocardiography, Female, Follow-Up Studies, Humans, Hypertension, Hypertrophy, Left Ventricular, Losartan, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Randomized Controlled Trials as Topic, Risk, Severity of Illness Index, Smoking, Stroke, Treatment Outcome",
author = "Larstorp, {A C K} and Okin, {P M} and Devereux, {R B} and Olsen, {M H} and H. Ibsen and B Dahl{\"o}f and Eigil Kjeldsen and Kristian Wachtell",
year = "2011",
doi = "10.1038/jhh.2010.52",
language = "English",
volume = "25",
pages = "178--85",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "3",
}